Farnesoid X Receptor Agonist Obeticholic Acid Reduces Kidney Disease in a Mouse Model of Alport Syndrome

被引:0
|
作者
Jones, Bryce A. [1 ]
Perry, Priscilla E. [1 ]
Davidson, Shania R. [1 ,2 ]
Santiago, Isabel Lopez [1 ,3 ]
Adapa, Sharmila [1 ]
Allen, Katherine C. [1 ]
Dial, Katelyn [1 ]
Rowland, Emma [1 ]
Myakala, Komuraiah [1 ]
Wang, Xiaoxin [1 ]
Levi, Moshe
机构
[1] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[2] Howard Univ, Coll Arts & Sci, Washington, DC 20059 USA
[3] Johns Hopkins Univ, Baltimore, MD USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
FR-PO688
引用
收藏
页码:511 / 511
页数:1
相关论文
共 50 条
  • [31] A LONG TERM SAFETY EXTENSION TRIAL OF THE FARNESOID X RECEPTOR (FXR) AGONIST OBETICHOLIC ACID (OCA) AND UDCA IN PRIMARY BILIARY CIRRHOSIS (PBC)
    Hirschfield, Gideon M.
    Mason, Andrew L.
    Gordon, Stuart C.
    Luketic, Velimir A.
    Mayo, Marlyn
    Vincent, Catherine
    Lindor, Keith D.
    Pares, Albert
    Kowdley, Kris V.
    Trauner, Michael
    Esguerra, Maria
    Boehm, Olaf
    Shapiro, David A.
    HEPATOLOGY, 2011, 54 : 429A - 429A
  • [32] FURTHER INCREASE IN BILIARY EXCRETION OF ASYMMETRIC DIMETHYLARGININE DURING HEPATIC ISCHEMIA/REPERFUSION INJURY BY OBETICHOLIC ACID, A FARNESOID-X-RECEPTOR AGONIST
    Di Pasqua, L. G.
    Berardo, C.
    Rizzo, V.
    Adorini, L.
    Richelmi, P.
    Vairetti, M.
    Ferrigno, A.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E55 - E55
  • [33] THE FARNESOID-X-RECEPTOR AGONIST OBETICHOLIC ACID FURTHER INCREASES BILIARY EXCRETION OF ASYMMETRIC DIMETHYLARGININE DURING HEPATIC ISCHEMIA/REPERFUSION INJURY
    Di Pasqua, L. G.
    Berardo, C.
    Rizzo, V.
    Adorini, L.
    Richelmi, P.
    Vairetti, M.
    Ferrigno, A.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S315 - S315
  • [34] OBETICHOLIC ACID, AN FXR AGONIST, REDUCES HEPATIC FIBROSIS IN A RAT MODEL OF TOXIC CIRRHOSIS
    Verbeke, L. D.
    Mannaerts, I.
    Schierwagen, R.
    Klein, S.
    Vander Elst, I.
    Windmolders, P.
    Farre, R.
    Wenes, M.
    Mazzone, M.
    Nevens, F.
    van Grunsven, L. A.
    Trebicka, J.
    Laleman, W.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S479 - S479
  • [35] Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand
    Junhui Yu
    Kui Yang
    Jianbao Zheng
    Wei Zhao
    Xuejun Sun
    Cancer Gene Therapy, 2021, 28 : 590 - 601
  • [36] Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand
    Yu, Junhui
    Yang, Kui
    Zheng, Jianbao
    Zhao, Wei
    Sun, Xuejun
    CANCER GENE THERAPY, 2021, 28 (06) : 590 - 601
  • [37] Regulation of Intestinal UDP-Glucuronosyltransferase 1A1 by the Farnesoid X Receptor Agonist Obeticholic Acid Is Controlled by Constitutive Androstane Receptor through Intestinal Maturation
    Weber, Andre A.
    Mennillo, Elvira
    Yang, Xiaojing
    van der Schoor, Lori W. E.
    Jonker, Johan W.
    Chen, Shujuan
    Tukey, Robert H.
    DRUG METABOLISM AND DISPOSITION, 2021, 49 (01) : 12 - 19
  • [38] Suppression of Lung Nitrogen Mustard-induced Pulmonary Fibrosis, Oxidative Stress and Inflammatory Macrophage Activation by the Farnesoid X Receptor Agonist, Obeticholic Acid
    Meshanni, J.
    Sun, R.
    Vayas, K.
    Guo, G.
    Gow, A.
    Laskin, J.
    Laskin, D. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [39] Obeticholic Acid Prevents Fibrosis in a Model of Tubulointerstitial Kidney Disease
    Davidson, Shania R.
    Adapa, Sharmila
    Lopez-Santiago, Isabel
    Dial, Katelyn
    Rowland, Emma
    Mykala, Komuraiah
    Wang, Xiaoxin
    Rosenberg, Avi
    Levi, Moshe
    Jones, Bryce A.
    FASEB JOURNAL, 2022, 36
  • [40] Agonist of farnesoid X receptor protects against bile acid induced damage and oxidative stress in mouse placenta - A study on maternal cholestasis model
    Wu, W. -B.
    Xu, Y. -Y.
    Cheng, W-W
    Wang, Y. -X.
    Liu, Y.
    Huang, D.
    Zhang, H. -J.
    PLACENTA, 2015, 36 (05) : 545 - 551